The Journal of Korean Diabetes最新文献

筛选
英文 中文
Prediction of Diabetic Neuropathy Using Machine Learning Techniques 使用机器学习技术预测糖尿病神经病变
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.238
J. Hyun
{"title":"Prediction of Diabetic Neuropathy Using Machine Learning Techniques","authors":"J. Hyun","doi":"10.4093/jkd.2022.23.4.238","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.238","url":null,"abstract":"Peripheral polyneuropathy is one of the most common complications in patients with diabetes mellitus, and it results in neuropathic pain, falling tendency, and foot ulcers as well as sensory and motor impairments. Numerous risk factors for diabetic neuropathy had been revealed through statistical analysis; however, statistics draw population inferences and might not be suitable for providing realtime prediction for each patient in clinical practice. Machine learning techniques were developed to find any predictive patterns based on input data. Such strategies can help predict neuropathy in diabetic patients, enabling prevention or early treatment to increase quality of life in diabetic patients. This article summarizes recent studies concerning the prediction of diabetic neuropathy using machine learning techniques, and suggests approaches for useful translation of these methods in the medical field.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134632895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetic Neuropathy and Risk of Cardiovascular Disease 糖尿病神经病变与心血管疾病的风险
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.245
J. Yun
{"title":"Diabetic Neuropathy and Risk of Cardiovascular Disease","authors":"J. Yun","doi":"10.4093/jkd.2022.23.4.245","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.245","url":null,"abstract":"Neuropathy is a common complication of diabetes that can appear in the early stages of diabetes or even in the prediabetes stage. The relationship between autonomic neuropathy and cardiovascular disease (CVD) is well established. Resting tachycardia, exercise intolerance, and non-dipping/reverse dipping caused by the relative overactivity of the sympathetic nervous system are the main factors that lead to the increased risk of CVD and cardiovascular mortality. Little is known, however, about the cardiovascular consequences of peripheral neuropathy (PN). Two recent major studies suggested the possibility of a significant association between PN and CVD and mortality; thus, cardiovascular risk management for patients with PN may be necessary. Positive results on MNSI (Michigan Neuropathy Screening Instrument) questionnaires and 10-g monofilament test are convenient methods for early screening and management of PN that may also be useful in evaluating PN-related CVD risk.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116380373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review the Change of Chronic Disease Care in Korea 回顾韩国慢性病护理的变化
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.251
Jeong rim Lee
{"title":"Review the Change of Chronic Disease Care in Korea","authors":"Jeong rim Lee","doi":"10.4093/jkd.2022.23.4.251","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.251","url":null,"abstract":"Globally, chronic diseases have a high burden and are a significant factor affecting society, such as through economic productivity and deepening social inequality. Deaths from chronic diseases in Korea accounted for 79.6% of all deaths as of 2021, and medical expenses from chronic diseases in Korea accounted for 85.0% of all national medical expenses as of 2020. Since the 1970s, chronic disease management in Korea has focused on projects such as acute infectious diseases, maternal and child health, and family planning by region, sporadically centered on universities. Since then, the importance of prevention and management of chronic diseases has been highlighted, and a comprehensive plan for national health promotion was established in 2002 to provide policy support. Here, we looked at the progress of the chronic disease management project and its effects and review suggestions for efficient establishment of a primary medical chronic disease management project to be carried out in the future.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127761153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Automated Insulin Delivery in Korean Clinical Practice 胰岛素自动输送在韩国临床中的应用
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.217
Sang-Man Jin
{"title":"Application of Automated Insulin Delivery in Korean Clinical Practice","authors":"Sang-Man Jin","doi":"10.4093/jkd.2022.23.4.217","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.217","url":null,"abstract":"In contrast to Europe and the United States (US), conventional insulin pumps have not been widely used in East Asia, even among people with type 1 diabetes. Clinical experiences in Europe and the US indicate that automated insulin delivery (AID) can successfully improve the quality of glucose control even in people with type 1 diabetes who do not have experience with conventional insulin pumps. Therefore, prior use of a conventional insulin pump was not a requirement for successful introduction of AID. However, use of AID still requires full understanding of conventional insulin pump management, and AID-specific education as well. Besides basic information on continuous glucose monitoring and conventional insulin pumps, people with type 1 diabetes starting AID should understand the difference between closed-loop and open-loop insulin delivery, should have reasonable expectations for AID, and should be motivated to engage in clinical follow-up to prevent discontinuation of the use of AID devices. Failure to provide AID-specific education before and after the introduction of AID would result in discontinuation of the use of AID devices, which would in turn result in suboptimal glucose control. In this review, I summarize lessons from clinical experience where AID is already in clinical use, and discuss what preparations should be made for successful introduction of AID in Korean clinical practice.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"77 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130834997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Intractable Painful Diabetic Peripheral Neuropathy: The Perspective of a Pain Specialist 难治性疼痛性糖尿病周围神经病变的管理:疼痛专家的观点
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.230
J. Moon
{"title":"Management of Intractable Painful Diabetic Peripheral Neuropathy: The Perspective of a Pain Specialist","authors":"J. Moon","doi":"10.4093/jkd.2022.23.4.230","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.230","url":null,"abstract":"Peripheral neuropathy is one of the most common complications of both type 1 and type 2 diabetes. The most common diabetic neuropathy (DN) is distal symmetric polyneuropathy, with characteristic glove- and stocking-like presentation of distal sensory or motor function loss. Because painful DN is associated with increased mortality and morbidity, early recognition and preventive measures are essential. Nevertheless, diagnosing DN or painful DN is challenging, particularly in patients with early and mild neuropathy, and there is no established gold standard. Furthermore, there is no established DN treatment other than improved glycemic control, and only symptomatic management is available for painful DN. However, thanks to health-conscious living, almost one-third of patients with painful DN derive sufficient pain relief with existing pharmacotherapies. These include antidepressants (tricyclic acid, serotonin-norepinephrine reuptake inhibitor), anticonvulsants (calcium-channel blocker, sodium channel blocker), and others (sarpogrelate). A more precise and distinct symptom profile from patients with painful DN may help identify patients more responsive to one treatment versus another. In addition to pharmacological, physical, cognitive, or educational management for painful DN, large randomized clinical trials are needed to identify the most effective minimally invasive interventions. Transcutaneous electrical nerve stimulation, pain scrambler therapy, sympathetic ganglion block, and botulinum toxin injections have been investigated as alternative therapeutic outcomes.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131185584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition Therapy for Diabetic Patients with Malnutrition 糖尿病营养不良患者的营养治疗
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.258
Min Ji Kim
{"title":"Nutrition Therapy for Diabetic Patients with Malnutrition","authors":"Min Ji Kim","doi":"10.4093/jkd.2022.23.4.258","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.258","url":null,"abstract":"Recently, the prevalence of diabetic mellitus patients in Korea has been increasing, and it increasing with age. The treatment goal of diabetes is to prevent complications through blood sugar management, for which it is important to maintain an appropriate nutritional state. Unbalanced diet refers to excessive or insufficient nutrition, which can be generally confirmed through weight conditions. Therefore, medical nutrition therapy in diabetic patients with unbalanced diet aims to maintain a moderate body mass index. Older people with diabetes have a higher risk of unbalanced diet than those without diabetes. Clinical nutritional intervention in diabetic patients should shift from strict dietary restrictions for treatment of metabolic syndrome/obesity to diet for prevention of frailty and sarcopenia with age. Therefore, clinical nutrition therapy for diabetic patients with unbalanced diet should be individualized in consideration of age, gender, and medical condition. Medical nutrition therapy tailored for each patient can contribute to improving the nutritional status of diabetic patients, prolonging healthy life expectancy and improving quality of life.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133107108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathogenesis and Treatment of Diabetic Peripheral Neuropathy 糖尿病周围神经病变的发病机制与治疗
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.222
Seon Mee Kang
{"title":"Pathogenesis and Treatment of Diabetic Peripheral Neuropathy","authors":"Seon Mee Kang","doi":"10.4093/jkd.2022.23.4.222","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.222","url":null,"abstract":"Diabetic neuropathy is the most common chronic complication of both type 1 and type 2 diabetes mellitus. Diabetic peripheral neuropathy (DPN), especially, distal symmetric polyneuropathy is the most common form of diabetic neuropathy. Pathogenesis of the DPN is associated with glycemic dysregulation, which results in activation of polyol, aldose reductase, hexosamine, and protein kinase C pathway and leads to downstream inflammation, generation of reactive oxygen species, and decreased blood flow to peripheral nerves. Furthermore, metabolic syndrome components such as obesity, insulin resistance, and dyslipidemia result in mitochondrial dysfunction and endoplasmic reticulum stress, eventually contributing to axonal failure and apoptosis of nerve cells. Despite its high prevalence, DPN is still underdiagnosed. Among DPN symptoms, neuropathic pain is challenging to manage, resulting in increased risk of associated problems such as sleep disturbance, reduced quality of life, and socioeconomic consequences. Therefore, early diagnosis and active multidisciplinary treatment of DPN is needed.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"742 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131921100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tirzepatide, A New Antidiabetic Drug with Change in the Treatment of Patients with Type 2 Diabetes 替西帕肽:一种新的抗糖尿病药物,对2型糖尿病患者治疗的影响
The Journal of Korean Diabetes Pub Date : 2022-12-31 DOI: 10.4093/jkd.2022.23.4.213
Soo Kyoung Kim
{"title":"Tirzepatide, A New Antidiabetic Drug with Change in the Treatment of Patients with Type 2 Diabetes","authors":"Soo Kyoung Kim","doi":"10.4093/jkd.2022.23.4.213","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.4.213","url":null,"abstract":"Mounjaro® (tirzepatide) was approved by the U.S. Food and Drug Administration for type 2 diabetes treatment in August 2022. Tirzepatide, a synthetic peptide consisting of 39 amino acids, is a dual GLP-1 (glucagon-like peptide-1)/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist. Tirzepatide showed marked reductions in glycated hemoglobin and body weight in the SURPASS study among participants with type 2 diabetes that surpassed existing diabetes drugs. Other benefits included blood pressure reduction and lipid lowering effects. On meta-analysis and post-hoc analysis, tirzepatide did not increase the risk of major cardiovascular events and is expected to have cardiovascular benefits in future studies. In addition, it showed a protective effect on the kidney by slowing the rate of renal function decline and reducing new-onset macroalbuminuria. However, the fact that it is an injectable drug, the cost of the drug, and the high rate of gastrointestinal side effects are disadvantages to tirzepatide. Considering the superior degree of glucose reduction and weight reduction observed in tirzepatide clinical trials compared to clinical trials of other anti-diabetic drugs, we expect tirzepatide to bring about a paradigm shift in the treatment of obese type 2 diabetes patients.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126330641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Nutrition Therapy for Weight Control in Obese Diabetic Patients 肥胖糖尿病患者控制体重的临床营养治疗
The Journal of Korean Diabetes Pub Date : 2022-09-30 DOI: 10.4093/jkd.2022.23.3.206
Mihyang Kim
{"title":"Clinical Nutrition Therapy for Weight Control in Obese Diabetic Patients","authors":"Mihyang Kim","doi":"10.4093/jkd.2022.23.3.206","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.3.206","url":null,"abstract":"Clinical Practice Guidelines for Diabetes recommend that overweight or obese adults lose more than 5% of their body weight and reduce their total caloric intake to maintain the reduced body weight. In diabetic patients, the goal of weight control is not simply to lose weight, but to achieve health benefits by controlling blood sugar well and reducing the risk of complications and other comorbidities. An extremely calorie-restricted diet, whose long-term effectiveness has not been verified, is not recommended as it may increase the risk of hypoglycemia and ketoacidosis. For weight control in obese diabetic patients, it is important to follow diabetic diet guidelines while setting actionable energy goals that prevent hypoglycemia and do not increase health risks. The energy target should be adjusted in consideration of individual conditions such as daily intake, body size, and activity level.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124277387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extent of Role: Anti-Diabetic Medications 作用范围:抗糖尿病药物
The Journal of Korean Diabetes Pub Date : 2022-09-30 DOI: 10.4093/jkd.2022.23.3.153
J. Hong
{"title":"Extent of Role: Anti-Diabetic Medications","authors":"J. Hong","doi":"10.4093/jkd.2022.23.3.153","DOIUrl":"https://doi.org/10.4093/jkd.2022.23.3.153","url":null,"abstract":"In management of diabetes, glucose lowering is the basic target of treatment. Insulin is essential to type 1 diabetes. Non-insulin therapy in type 2 diabetes is very diverse and continuously developing to improve glucose control and prevent diabetes-related complications. In the recent 30 years, recommended specifications of anti-diabetic drugs are high glucose-lowering efficacy, low risk of hypoglycemia, less burden of weight gain, and cardiovascular safety. With development of SGLT2 inhibitors (sodium glucose cotransporter 2 inhibitors) and GLP-1RA (glucagon-like peptide-1 receptor agonist), the clinical benefits also include risk reduction of diabetes-related complications (hospitalization for heart failure, chronic kidney disease, atherosclerotic cardiovascular disease), even in non-diabetic patients. Anti-diabetic medication can have a role in holistic management for prevention and treatment of diabetes and diabetes-related complications, as well as an improvement of mortality.","PeriodicalId":366252,"journal":{"name":"The Journal of Korean Diabetes","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128922110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书